At Araclon Biotech, a Grifols company, we focus on the early diagnosis and preventive treatment of Alzheimer’s disease.
We are pioneers in plasma-based assays for detecting amyloid peptides and have developed ABvac40, an innovative vaccine targeting Aβ40 to slow disease progression. Since our founding in 2004 by Prof. Manuel Sarasa Barrio as a spin-off from the University of Zaragoza, we have grown into a leader in Alzheimer’s research, committed to scientific excellence and innovation.
As part of Grifols, we continue to develop groundbreaking solutions that improve the lives of individuals affected by neurodegenerative diseases.
Company Details
- Employees
- 21
- Founded
- -
- Address
- Avda. Hispanidad, 21,spain
- Industry
- Biotechnology
- Website
- araclonbiotech.com
- Keywords
- Biotecnología.
- HQ
- ZARAGOZA, ESPAÑA
Araclon Biotech, S.l. Questions
Araclon Biotech, S.L.'s website is araclonbiotech.com
Araclon Biotech, S.L.'s LinkedIn profile is https://es.linkedin.com/company/araclon-biotech-s-l-
Araclon Biotech, S.L. has
21 employees.
View email and phone details for 21
employees at Araclon Biotech, S.L..
Araclon Biotech, S.L.'s industry is
Biotechnology
Araclon Biotech, S.L.'s top competitors are
Citogen,
Operon,
Certest Biotec, S.l.,
Nanoimmunotech Sl,
Bdr- Blackhills Diagnostic Resources,
Diagnostica Longwood,
Exopol,
Zeulab,
Bioclonal,
Certest Pharma.
Araclon Biotech, S.L.'s categories are Biotechnology
Araclon Biotech, S.L.'s founding year is 2003
